AHR:NYE-American Healthcare REIT, Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 29.49

Change

0.00 (0.00)%

Market Cap

USD 4.18B

Volume

1.74M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
AHR VTI
  • VTI
Relative Returns (From:    To: 2025-03-16 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+3.42 (+2.31%)

USD 94.56B
VTR Ventas Inc

+1.86 (+2.78%)

USD 29.24B
DOC Healthpeak Properties Inc

+0.04 (+0.20%)

USD 14.30B
CTRE CareTrust REIT Inc.

+0.39 (+1.37%)

USD 4.68B
NHI National Health Investors Inc

+0.39 (+0.52%)

USD 3.43B
LTC LTC Properties Inc

+0.01 (+0.03%)

USD 1.64B
UHT Universal Health Realty Income..

+0.25 (+0.60%)

USD 0.54B
CHCT Community Healthcare Trust Inc

+0.35 (+1.91%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
GMRE Global Medical REIT Inc

N/A

N/A

ETFs Containing AHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.76% 40% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.76% 40% F 75% C
Trailing 12 Months  
Capital Gain 117.00% 100% F 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 117.00% 100% F 98% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A 37% F
Dividend Return N/A N/A N/A 25% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A 80% B-
Risk Adjusted Return N/A N/A N/A 27% F
Market Capitalization 4.18B 60% D- 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector